Skip to content

LIQTECH INTERNATIONAL, INC.

NASDAQ: LIQT

Company: LiqTech International, Inc.
Ticker: Nasdaq: LIQT
Sector: Industrials
Investor Contact: Robert Blum

LiqTech International Financials

Financials – Current & Historical

CONDENSED CONSOLIDATED BALANCE SHEETS (CURRENT PERIOD UNAUDITED)
v3.23.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash and restricted cash $ 12,594,689 $ 16,597,371
Accounts receivable, net of allowance for doubtful accounts of $50,230 and $59,559 at June 30, 2023 and December 31, 2022, respectively 2,960,421 2,310,344
Inventories, net of allowance for excess and obsolete inventory of $732,638 and $663,227 at June 30, 2023 and December 31, 2022, respectively 4,423,280 4,062,001
Contract assets 2,406,402 2,253,295
Prepaid expenses and other current assets 2,816,823 1,720,902
Assets held for sale 694,601 723,872
Total Current Assets 25,896,216 27,667,785
Long-Term Assets:    
Property and equipment, net of accumulated depreciation of $10,374,274 and $9,046,499 at June 30, 2023 and December 31, 2022, respectively 7,526,475 8,296,807
Operating lease right-of-use assets 3,046,933 3,271,997
Deposits and other assets 457,111 450,038
Intangible assets, net of accumulated amortization of $497,445 and $438,250 at June 30, 2023 and December 31, 2022, respectively 164,978 212,933
Goodwill 229,999 226,095
Total Long-Term Assets 11,425,496 12,457,870
Total Assets 37,321,712 40,125,655
Current Liabilities:    
Accounts payable 1,963,042 1,389,355
Accrued expenses 2,998,844 3,087,206
Current portion of finance lease obligations 413,505 399,198
Current portion of operating lease liabilities 589,127 561,182
Contract liabilities 878,201 649,557
Total Current Liabilities 6,842,719 6,086,498
Deferred tax liability 128,542 154,645
Finance lease obligations, net of current portion 2,216,535 2,384,011
Operating lease liabilities, net of current portion 2,457,806 2,710,815
Senior promissory notes payable, less current portion 5,651,632 5,480,314
Total Long-term Liabilities 10,454,515 10,729,785
Total Liabilities 17,297,234 16,816,283
Stockholders' Equity:    
Preferred stock; par value $0.001, 2,500,000 shares authorized, 0 shares issued and outstanding at June 30, 2023 and December 31, 2022 0 0
Common stock; par value $0.001, 12,500,000 shares authorized, 5,700,226 and 5,498,260 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 5,700 5,498
Additional paid-in capital 97,326,371 96,975,476
Accumulated deficit (71,295,830) (67,351,035)
Accumulated other comprehensive loss (6,011,763) (6,320,567)
Total Stockholders' Equity 20,024,478 23,309,372
Total Liabilities and Stockholders' Equity $ 37,321,712 $ 40,125,655
CONDENSED CONSOLIDATED BALANCE SHEETS (CURRENT PERIOD UNAUDITED) (PARENTHETICALS)
v3.23.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Accounts receivable, allowance for doubtful accounts $ 50,230 $ 59,559
Inventories, allowance for excess and obsolete inventory 732,638 663,227
Property and equipment, accumulated depreciation 10,374,274 9,046,499
Intangible assets, accumulated depreciations $ 497,445 $ 438,250
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 2,500,000 2,500,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shared outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 12,500,000 12,500,000
Common stock, issued (in shares) 5,700,226 5,498,260
Common stock, outstanding (in shares) 5,700,226 5,498,260
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue $ 4,990,019 $ 5,018,292 $ 9,001,538 $ 8,655,528
Cost of Goods Sold 3,827,491 4,870,152 7,447,668 8,261,847
Gross Profit 1,162,528 148,140 1,553,870 393,681
Operating Expenses:        
Selling expenses 1,028,225 1,196,513 2,210,660 2,256,461
General and administrative expenses 1,377,483 1,265,543 2,436,432 3,182,060
Research and development expenses 359,784 490,836 702,403 1,093,573
Restructuring costs 0 1,788,827 0 1,788,827
Total Operating Expense 2,765,492 4,741,719 5,349,495 8,320,921
Loss from Operations (1,602,964) (4,593,579) (3,795,625) (7,927,240)
Other Income (Expense)        
Interest and other income 116,545 342,624 168,218 342,723
Interest expense (45,898) (159,557) (57,899) (366,018)
Amortization discount on Notes (86,790) (1,922,618) (171,318) (2,219,956)
Gain (Loss) on currency transactions 49,494 (342,202) (116,784) (266,209)
Gain on lease termination 0 153,575 0 153,575
Gain on sale of fixed assets 0 661 0 661
Total Other Income (Expense) 33,351 (1,927,517) (177,783) (2,355,224)
Loss Before Income Taxes (1,569,613) (6,521,096) (3,973,408) (10,282,464)
Income Tax Benefit (14,321) (14,037) (28,613) (28,981)
Net Loss $ (1,555,292) $ (6,507,059) $ (3,944,795) $ (10,253,483)
Basic and Diluted Loss Per Share (in dollars per share) $ (0.27) $ (1.62) $ (0.70) $ (3.07)
Basic and Diluted Weighted Average Common Shares Outstanding (in shares) 5,660,007 4,012,187 5,656,809 3,344,208
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)
v3.23.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Net income (loss) $ (1,555,292) $ (6,507,059) $ (3,944,795) $ (10,253,483)
Other Comprehensive Income (Loss) - Currency Translation, Net (99,792) (614,575) 308,804 (970,466)
Total Comprehensive Loss $ (1,655,084) $ (7,121,634) $ (3,635,991) $ (11,223,949)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities:    
Net Loss $ (3,944,795) $ (10,253,483)
Adjustments to reconcile net loss to net cash provided by (used in) operations:    
Depreciation and amortization 1,530,282 1,683,679
Amortization of discount on convertible notes payable 171,318 2,219,956
Stock-based compensation 351,097 400,250
Change in deferred tax asset / liability (28,613) (28,981)
Gain on lease termination 0 (153,575)
Gain on sale of fixed assets 0 (661)
Changes in assets and liabilities:    
Accounts receivable (606,781) (660,578)
Inventory (289,557) (504,315)
Contract assets (113,442) (1,102,662)
Prepaid expenses and other current assets (1,061,699) (2,360,975)
Accounts payable 548,581 432,337
Accrued expenses (135,214) (178,716)
Operating lease liabilities (279,983) (268,816)
Contract liabilities 60,584 (255,701)
Assets held for sale 41,534 0
Total Adjustments 188,109 (778,758)
Net Cash used in Operating Activities (3,756,688) (11,032,241)
Cash Flows from Investing Activities:    
Purchase of property and equipment (290,468) (229,865)
Proceeds from sale of fixed assets 0 661
Net Cash used in Investing Activities (290,468) (229,204)
Cash Flows from Financing Activities:    
Payments on finance lease obligation (200,095) (179,689)
Proceeds from issuance of Common Stock and prefunded warrants 0 24,453,528
Proceeds from issuance of Senior Promissory Notes 0 6,000,000
Payments on Convertible Note 0 (16,800,000)
Net Cash used in Financing Activities (200,095) 13,473,839
Gain (Loss) on Currency Translation 244,569 (6,052)
Net change in Cash and Restricted Cash (4,002,682) 2,206,342
Cash and Restricted Cash at Beginning of Period 16,597,371 17,489,380
Cash and Restricted Cash at End of Period 12,594,689 19,695,722
Supplemental Disclosures of Cash Flow Information:    
Interest (98,069) 444,297
Income Taxes $ 0 $ 0
Arrow